Welcome to JOURNAL OF SICHUAN UNIVERSITY (MEDICAL SCIENCES) May 29, 2025
ZHOU Yin, ZHAO Shuang, BAI Jiao, et al. The Diagnostic Value of Conventional MRI in the Differentiation of Malignant Tumor from Benign Lesion in Prostatic Peripheral Zone[J]. Journal of Sichuan University (Medical Sciences), 2013, 44(1): 94-98.
Citation: ZHOU Yin, ZHAO Shuang, BAI Jiao, et al. The Diagnostic Value of Conventional MRI in the Differentiation of Malignant Tumor from Benign Lesion in Prostatic Peripheral Zone[J]. Journal of Sichuan University (Medical Sciences), 2013, 44(1): 94-98.

The Diagnostic Value of Conventional MRI in the Differentiation of Malignant Tumor from Benign Lesion in Prostatic Peripheral Zone

More Information
  • Received Date: May 17, 2012
  • Revised Date: July 25, 2012
  • Published Date: January 19, 2013
  • Objective To evaluate the diagnostic capabilities of conventional MRI (T1WI, T2WI and Gd-enhancement T1WI) for differentiating prostate cancer from benign prostatic disorders in prostatic peripheral zone (PZ). Methods Respectively analyze the characteristics of conventional MRI in 46 cases of prostate cancer and 25 cases of benign prostatic disorders (with 28 lesions). Six indexes were initially screened by χ2-test, and receiver operating characteristic curves (ROC) of these indexes were depicted, then Bayes discriminator was applied to discriminate all the lesions according to the indexes with statistic meaning. The discriminant function was evaluated with new sample validation. Results The indexes showing statistics meaning between prostate cancer and benign prostatic disorders were uniform low SI on T2WI, shape, pseudocapsule extension, prostate-capsule extension, size change of PZ with lesion and enhancement style. Furthermore, uniform low SI on T2WI, enhancement style and size change of PZ with lesion were consist of the function after discrimination, AUC of these 3 indexes were all above 0.7, which were wider than that of the other 3 indexes. The discriminating accuracy rates of the new sample for benign prostatic disorders and prostate cancer were 83% and 77%. Conclusion The importance of uniform low SI on T2WI, enhancement style and size change of PZ with lesion should be highlighted in the differentiation of prostate cancer and benign prostatic disorders in PZ.
  • [1]
    Yamamura J, Salomon G, Buchert R, et al. Magnetic resonance imaging of prostate cancer: diffusion-weighted imaging in comparison with sextant biopsy. J Comput Assist Tomo,2011;35(2):223-228.
    [2]
    Umbehr M, Bachmann LM, Held U, et al. Combined magnetic resonance imaging and magnetic resonance spectroscopy imaging in the diagnosis of prostate cancer: a systematic review and meta-analysis. Eur Urol,2009;55(3):575-590.
    [3]
    Ohori M, Kattan MW, Koh H, et al. Predicting the presence and side of extracapsular extension: a nomogram for staging prostate cancer. J Urology,2004;171(5):1844-1849.
    [4]
    Bloch BN, Furman HE, Helbich TH, et al. Prostate cancer: accurate determination of extracapsular extension with high-spatial-resolution dynamic contrast-enhanced and T2-weighted MR imaging——initial results. Radiology,2007;245(1):176-185.
    [5]
    Kahn T, Burrig K, Schmitz DB, et al. Prostatic carcinoma and benign prostatic hyperplasia: MR imaging with histopathologic correlation. Radiology,1989;173(3):847-851.
    [6]
    Langer DL, Vander KTH, Evans AJ, et al. Prostate tissue composition and MR measurements: investigating the relationships between ADC, T2, K(trans), v(e), and corresponding histologic features. Radiology,2010;255(2):485-494.
    [7]
    Gibbs P, Liney GP, Pickle MD, et al. Correlation of ADC and T2 measurements with cell density in prostate cancer at 3.0 Tesla. Invest Radiol,2009;44(9):572-576.
    [8]
    Engelhard K, Hollenbach HP, Deimling M, et al. Combination of signal intensity measurements of lesions in the peripheral zone of prostate with MRI and serum PSA level for differentiating benign disease from prostate cancer. Eur Radiol,2000;10(12):1947-1953.
    [9]
    Offersen BV, Borre M, Overgaard J. Immunohistochemical determination of tumor angiogenesis measured by the maximal microvessel density in human prostate cancer. APMIS,1998;106(4):463-469.
    [10]
    Foley SJ, Bailey DM. Microvessel density in prostatic hyperplasia. Bju Int,2000;85(1):70-73.
    [11]
    黄 嵘, 王霄英, 王 刚等.前列腺癌的MRI诊断价值及其误诊原因分析. 临床泌尿外科杂志,2005;20(6):352-354.
    [12]
    Shukla-Dave A, Hricak H, Eberhardt SC, et al. Chronic prostatitis: MR imaging and 1H MR spectroscopic imaging findings——initial observations. Radiology,2004;231(3):717-724.

Catalog

    Article views (2691) PDF downloads (47) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return